Marmara University School of Medicine Urology Department
Istanbul, Pendik, 34854, Turkey (Türkiye)
NCT Number: NCT07304297
The goal of this prospective clinical trial is to evaluate how intraoperative tidal volume settings affect surgical parameters and outcomes in adult patients undergoing flexible ureteroscopy (fURS) for kidney stones. The participant population includes patients over 18 years of age with unilateral, single renal stones located in the upper/middle calyx or renal pelvis.
This study aims to answer are:
Does intraoperative tidal volume influence operative time and surgical efficiency during fURS?
Does tidal volume affect laser energy use, lasing efficiency, stone-free rates, and complication rates (infection or bleeding)?
The investigators will compare two groups based on tidal volume recorded during anaesthesia:
Group 1: Low tidal volume (< 500 mL)
Group 2: Standard tidal volume (≥ 500 mL)
to determine whether tidal volume differences impact surgical performance and postoperative outcomes.
Participants will:
Undergo fURS performed under general anaesthesia with standard ASA monitoring, including ETCO₂ and TOF monitoring.
Have their respiratory parameters (tidal volume, peak airway pressure, PEEP, respiratory rate, ETCO₂) and surgical data (operative time, laser settings, fluoroscopy use, stone-free status) recorded during and after surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Istanbul, Pendik, 34854, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age ≥18 years
Unilateral, single kidney stones located in the upper or middle calyx or in the renal pelvis
Exclusion criteria
Chronic obstructive pulmonary disease (COPD)
Pregnancy
History of abdominal, retroperitoneal, or thoracic surgery
Kidney anomalies
Stones located in the lower calyx
Between October 2025 and December 2025, Patients who underwent fURS surgery in our clinic, with the surgical indication determined according to the EAU guidelines, were included in the study. Patients over 18 years of age with unilateral, single stones located in the upper or middle calyx or in the renal pelvis were included in the study. Patients with chronic obstructive pulmonary disease, pregnancy, a history of abdominal, retroperitoneal, or thoracic surgery, kidney anomalies, or stones located in the lower calyx were excluded.
Time frame: 2 months
Respiratory parameter measured:
Tidal Volume (mL/kg)
Measurement tool: Anaesthesia ventilator/monitoring system
Unit: milliliters per kilogram (mL/kg)
Surgical outcomes assessed:
Stone-free rate (%), assessed by postoperative non-contrast CT scan
Operative time (minutes), recorded from surgical logs
Complications, graded using the Clavien-Dindo classification
The objective is to determine the statistical correlation between tidal volume and each of these surgical outcomes.
Time frame: 2 months
Operative time (minutes), recorded from surgical logs
Surgical efficiency (stone volume / operative time, mm³/min)
Laser time (seconds), recorded from laser console
Laser energy used (Joules), recorded from laser console
Lasing efficiency (stone volume / lasing time, mm³/sec)
Complications, graded using the Clavien-Dindo classification
Bleeding rate (%), incidence of significant intra- or postoperative bleeding
Infection rate (%), incidence of postoperative urinary tract infection
Length of hospital stay (days), total postoperative hospitalization
Tarik Emre Sener
Other
Impact of Intraoperative Tidal Volume on Surgical Parameters During Flexible Ureteroscopy
Acronym: TIDAL-fURS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02214836
Calculi, Female Urogenital Diseases
Seattle, Washington, United States
View Trial DetailsNCT07445646
Calculi, Female Urogenital Diseases
Zagazig, Egypt
View Trial DetailsNCT07555535
Airway Management, Female Urogenital Diseases
Yenimahalle, Ankara, Turkey (Türkiye)
View Trial DetailsNCT04490343
Calculi, Deep Learning Reconstruction
Amiens, France
View Trial Details